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It is becoming more and more evident that infection with MuLV  I (Gross),  in one 
form or another, is virtually ubiquitous among mice. Mice of strains with a  high in- 
cidence of  spontaneous leukemia  (e.g.  AKR  and C58)  are  overt  carriers,  MuLV- 
associated antigens being demonstrable in their tissues throughout life; other mice 
(e.g.  C3Hf/Bi)  show  these signs of infection only in later life; still other mice (e.g. 
C57BL/6 and BALB/c)  rarely or never do so even in later life,  but their tumors, 
induced or spontaneous, and also cultured normal tissues from  these strains often 
produce both MuLV virions and MuLV antigens (see 1-15 for references). Further- 
more, MuLV antigen is demonstrable in probably all mouse embryos at some stage of 
development (16). It seems therefore that evidence for MuLV infection could be ob- 
tained at will for any mouse of any strain. 
Long before these facts were appreciated, an intimate association between MuLV 
and the gametes was suspected as an explanation of vertical transmission of infection, 
i.e.,  the regular congenital transmission of virus by females and males of the AKR 
and other mouse strains with a high incidence of leukemia (15, 17). The closest form 
of such an association would be chromosomal integration of  the viral genome as in 
lysogeny, and this has been much discussed. 
A  number of recent findings tend to substantiate this hypothesis: (a)  It is now 
realized that viral ribonucleic acid (RNA)  can be transcribed into deoxyribonucleic 
acid  (DNA)  (18-21), which  allows  for  DNA  copies  of  RNA  viral  genomes  like 
MuLV, as proposed originally by Temin for Rous sarcoma virus (22).  (b) In certain 
chicken populations, the group-specific  (gs) antigen of  avian leukosis-sarcoma virus 
can be inherited as a mendelian dominant, as if the viral gene coding for this antigen 
were incorporated in one of the chicken's chromosomes (23).  (c) Bentvelzen's demon- 
stration that in mice of the GR strain the propensity to develop mammary neoplasia 
is inherited as a mendelian dominant is difficult to explain on any basis other than 
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integration of mammary tumor virus genes in one of the chromosomes of this stock of 
mice (24). 
We have been investigating a  new MuLV-related cell surface antigen which 
is present  on lymphoid cells of normal mice. It requires  two unlinked  chromo- 
somal genes for its expression,  and we have called it Gix (G  -  Gross)  because 
one of these two genes has been located in linkage group IX. 
The antigens of MuLV (Gross)  include group-specific (gs:internal)  and type-specific (en- 
velope) components of the virion, recognized by immunodiffusion, complement fixation, virus 
neutralization, and irnmunoelectronmicroscopy. In addition, the cytotoxicity test identifies G 
(Gross)  cell surface antigen (GCSA), a type-specific nonvirion antigen expressed  on the surface 
of infected cells and rendering them susceptible to lysis by cytotoxic  Gross  antiserum  and 
complement. Another type-specific nonvirion antigen, Gross soluble antigen (GSA), is found 
in serum and in tissue extracts and is demonstrable by immunofluorescence of viable indicator 
ceils to which it has been adsorbed; it may represent exfoliated G cell surface antigen. (refer- 
ences and summary in Table I). 
TABLE  I 
Previously Reported Antigens of the MuLV (Gross) System 
Description  Abbreviation  Virion or nonvirion  Serological technique  References 
Group-spec- 
ific antigen 
Virion 
envelope 
antigen 
Gross cell 
surface 
antigen 
Gross soluble 
antigen 
gs 
Ve 
GCSA* 
GSA 
Virion 
Virion (type-specific) 
Nonvirion (cellular) 
Nonvirion noncellular 
(possibly same 
specificity as GCSA, 
may be exfoliated 
GCSA) 
Ouchterlony, C fixation 
Virus  neutralization,  im- 
munoelect  ronmicroseopy 
Cytotoxic (mouse)  anti- 
body, immunoelectron- 
microscopy 
Immunofluorescence of 
indicator cells carrying 
adsorbed GSA 
5, 7, 25- 
29 
4,  5,  30 
1,  3,  5, 
30-32 
* Now that we recognize the new MuLV-associated antigen Gix (described in this report), 
we shall refer to  the  Gross  cell surface antigen  identified  by  mouse  antiserum  as  GCSA 
rather than simply G  (as previously, ref.  1)  to distinguish the notation more clearly from 
GIX. 
:~ Strains like AKR have a  high incidence of leukemia and  are overt lifelong carriers of 
MuLV (Gross); GCSA is demonstrable on their spleen and lymphoid tissues at all ages, and 
so these strains are referred to as GCSA  + in contrast to other strains  (GCSA-) which only 
manifest GCSA late in life or not at all (1). GCSA is demonstrable on thymocytes of GCSA  + 
mice by serological absorption,  but the amount is so small that the antiserum,  anti-GCSA 
(rat),  has only negligible cytotoxic activity on GCSA  +  thymocytes. The standard  test for 
GCSA on any cell population is therefore to test their capacity to absorb cytotoxic activity 
from  C57BL/6 anti-K36  (AKR  leukemia)  serum,  the  absorbed  serum  being  tested  on  a 
standard syngeneic C57BL/6 leukemia which is highly sensitive to the antiserum  (1). 1336  Tm~  GIX  SYSTEM 
Past  analysis has been based mainly on  Gross  antiserum from  two  sources, 
the mouse (1)  and the rat (5,  7). The latter antiserum,  prepared in inbred rats 
against syngeneic leukemias induced by Gross virus, identifies a  more extensive 
range  of  Gross  specificities  than  the  mouse  antiserum  (5,  and  see  Table  I). 
Among  these  additional  antibodies  found  in  the  rat  antiserum  is  one  that  is 
strongly  cytotoxic  for  thymocytes  of  certain  mouse  strains.  We  shall  call  it 
anti-Gix  for  the reasons  given above;  the immunogenetic  system  it defines is 
the subject of  this report. 
Materials and Methods 
Mice and  Rats.--With the following exceptions,  all mice,  and rats of the  W/Fu  inbred 
strain, were from our own colonies. Strains designated/J and those based on C57BL/10 (B 10) 
were purchased from The Jackson Laboratory, Bar Harbor, Maine. Strain 129 mice were ob- 
tained from our own co|ony and from The Jackson Laboratory. All strain 129 breeders for 
genetic tests were taken from our own colony (originating from 129 breeders supplied by Dr. 
D. B. Amos in 1963). Dr. L. C. Stevens kindly sent mice of his various  129 sublines for com- 
parative tests. 
Thymocytes for Serological Tests.--Where it was necessary to preserve the donors,  thymo- 
cytes were obtained from anesthetized living mice by suction through a  special  pipette  in- 
serted into the chest via the thoracic inlet, yielding all or part of one thymic lobe (33). 
Serology.--Where  technical details have  been  described  fully  elsewhere,  only pertinent 
references will be given. 
Cytotoxicity test (34, 33): The maximum accepted background level of cell death in control 
cells exposed to complement alone or antiserum alone, or to complement and antiserum com- 
bined in the case of control cells not carrying the relevant antigen, was 15%. 
Complement for the cytotoxlcity test: Serum from rabbits individually selected for low toxicity 
for mouse thymocytes combined with a high complement level (36) was used at 1 : 15 (= dilu- 
tion before use). Heteroantibody in these selected rabbit sera is not detectible at this dilution, 
therefore prior absorption with mouse cells is unnecessary. 
Antiserum for Gzx specificity:  This is the standard  Gross antiserum  (W/Fu  X  BN)F1 
(rat)  anti-W/Fu(C58NT)D  (5,32).  W/Fu(C58NT)D  is  a  transplanted  W/Fu  leukemia 
induced by wild-type MuLV. Various pools were used, all heated at 56°C for 30 min to elimi- 
nate complement activity. All antibodies in this antiserum (excluding natural heteroantibody) 
are directed to antigens of the MuLV (Gross) system (see Table I). Gix specificity is identified 
by the reaction of this antiserum with mouse thymocytes that carry this antigen: usual titer 
vs.  strain  129  tbymocytes  =  1:400.  Rat  heteroantibody reactive with mouse  thymocytes 
was removed as necessary by absorption (in the cold)  with thymocytes and spleen cells of 
Gix-  strains (see Table II, prototype =  C57BL/6). The natural heteroantibody has partial 
mouse strain specificity, therefore absorption with cells of one particular Gix-  strain may 
not remove all activity against another Gix- strain; this was taken into account in absorbing 
antiserum for particular purposes, e.g. in linkage tests involving CBA, CBA thymocytes were 
included in the preparatory absorption of heteroantibody. 
G rx-typing:  distinction  of heterozygotes from positive  homozygotes in segregating populations 
of mice from Gzx 3 X  Grx-crosses (Tables V, VII, VIII, and IX): The cytotoxic reaction on 
positive homozygotes is much greater than on heterozygotes in the Gix system. Scoring of 
thymocytes is therefore easy by the direct cytotoxicity test, the former are >90% lysed and 
the latter <60% (maximum) lysed in a standard test with 1:20 antiserum. 
G ~x-typing:  distinction  o[ heterozygotes from negative homozygotes in segregating populations 
of mice from Gix '~ X  Gtx-crosses" (Tables VI, VII, and  VIII):  For this purpose,  the  rela- 
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to distinguish heterozygotes from negative homozygotes directly  by the  cytotoxicity  test. 
Therefore typing of thymocytes was in this case performed by absorption under previously 
standardized conditions, (0.06 ml of antiserum diluted 1:200 absorbed with 15 X l0  s thymo- 
cytes of mouse to be typed and then tested on 129 thymocytes). 
Quantitative estimation of Gzx antigen (Fig. 2 and Table I1): This was performed by ab- 
sorption of antiserum samples (1:200) with a range of counted cell  numbers followed by cyto- 
toxicity tests of the absorbed samples on 129 thymocytes (details in 37). 
Typing  of calls for presence or absence of G1x and GCSA  antigens (Tables Ill  and  IV): 
Except where the number of cells available was limited, as in the typing of thymocytes of 
individual living mice (see above), portions of the rat antiserum, diluted nearly to the end- 
point, were absorbed (30 rain in the cold) with equal volumes of washed packed cells of the 
tissue to be typed for Gix followed by cytotoxicity testing of the absorbed antiserum on 129 
thymocytes.  For GCSA-typing the standard  reference antiserum  C56BL/6  anti-AKR leu- 
kemia K36 (1) was used with the standard  test cell C57BL/6 leukemia EcPG2 induced by 
MuLV (Gross Passage A), the standard procedure described in reference 1. 
RESULTS 
I.  Representation  of G,x  Antigen  on  Mouse  Thymocytes  of  Various  Strains 
(Figs. i  and 2, Table II).--There are marked strain differences in the sensitivity 
TABLE II 
Quantitative Representation of G1x Antigen on Thymocytes of Various Mouse Strains 
GIX  3 
GIX 2 
GIx  1 
GIX- 
129  (and  129/Sv,  129/Sv-S1JCP+/+,  129/Sv-S1JCP/+,  129/Rr,  129/ReJ-dy 
TER/Sv) ;* CE/J 
C58; AKR (and AKR.K, AKR/H-2b) ; A (and A/TL-, A/0-AKR) ; I; C3H/He 
SJL/J; DBA/2; C3H/An; 101 
C57BL/6  (and  C57BL/H-2 k,  C57BL/TL +,  C57BL/Ly-A.1,  C57BL/Ly-B.1); 
C57BL/10/J  [and B10.129(SM), B10.129(9M), B10.129(10M), B10.129(12M), 
B10.129(13M)]; BALB/c,  [and  TJ(TJ/+)];  CBA/J;  CBA-T6(Lyon);  RF/J; 
DBA/1/J; MA/J; SWR; H-2H; H-2I; H-2G; C57BR/J; C3Hf/Bi  (when young; 
see text) 
Convention for expressing quantitatively the representation  of Gix antigen on thymo- 
cytes of various strains: 
Gix  3  Highest quantity (129 and CE strains only) 
GIx  2  Intermediate quantity (approximately/25 of 129 quantity) 
GIx 1  Low quantity (approximately/1~ of 129 quantity) 
Gix-  No demonstrable antigen 
* Congenic strains are grouped in parenthesis  after  the respective  strains  whose main 
genotype they share. 
of mouse thymocytes to anti-Gix serum in the cytotoxicity test. Most strains 
fall into one or another of four categories indicated in Fig.  1: GIx  ÷  with  (a) 
high, (b) intermediate or (c) low sensitivity, or (d) G,x- (completely insensitive). 
This suggested either that there are quantitative strain differences in repre- 
sentation of Gix or that more than one specificity is involved. The latter was 
ruled  out by cross-absorption, which  showed  that  thymocytes of  each  Gix  + 
strain absorbed all cytotoxic activity for  all  other  Gix  +  strains.  Quantitative 1338  THE  GIX  SYSTEM 
absorptions  (Fig.  2)  confirm  that  these  strain  differences  are  in  fact  due  to 
characteristic  differences  in  the  quantity  of  G~x  on  thymocytes  of different 
strains.  Fig. 2 also illustrates  that the amounts of G~x in the three G~x  + cate- 
gories stand approximately in the ratios 3:2:1, so we shall adopt the notation 
G~x  3,  Gzx  2,  and  Gix 1 for distinguishing  the  three  G,x  +  phenotypes.  For con- 
venience, we shall use the same symbols for the genotypes. 
Fig. 2 includes two examples of 50 % representation of Gzx on thymocytes of 
Gix +  X  G1x- hybrids as compared with the homozygous GL~  + parent. 
60 
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FIG.  1. Strain  differences in  sensitivity  of  thymocytes to  anti-Gix  serum. Cytoto×ic 
activity of anti-Gix serum on thymocytes of four mouse strains representing the three Gix  + 
categories Gix 3 (129), Gix  ~ (I), Gix 1 (C3H/An), and the fourth category Gix- (C57BL/6). 
Table II shows the strain distribution of the four G~x phenotypes. These do 
not  correspond  with  GCSA  phenotypes,  many  strains  being  G~x+:GCSA  -. 
Neither is there  correspondence with any known system of alia-antigens,  and 
in any event the quantitative  strain differences in Gix representation  have no 
close counterpart in known systems of allo-antigens. 
II.  Tissue Representation of Grx Antigen (Determined by Absorption).--In 
normal mice,  G~x is  exclusively an  antigen  of lymphoid cells.  The extent  to 
which it is represented on lymphocytes from different lymphoid organs depends 
upon whether  or not  the  mouse belongs  to a  GCSA- strain  or  to  a  GCSA  + 
strain (strain carrying MuLV as a lifelong overt infection, prototype AKR, see 
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(a)  In 129, which is the prototype Gix+: GCSA- strain,  Gix is demonstrable 
only on thymocytes,  except in  aged mice when it may be detectible  also on 
cells from spleen and lymph nodes. (b) In AKR, which is the prototype G~x+: 
GCSA  + strain,  Gix is easily demonstrable in all lymphoid tissues throughout 
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FIG. 2.  Estimation of the amount of Gxx antigen on thymocytes of various mouse strains 
and their hybrids by quantitative absorption  (four selected representative tests). Four cate- 
gories are recognizable, according to the amount of Gix antigen expressed: Gix  3 (high; 129 
and  CE),  GIx  2 (intermediate; C58,  A  and  I),  Gix 1 (low;  SJL and  C3H/An),  and  GIX- 
(C57BL/6 and  young C3Hf/Bi mice).  Figs. A, B, C, and  D  refer  to  four  separate  tests, 
therefore comparison  of cell numbers  required  for  absorption  (arrows)  are  valid  only in- 
ternally within each of the four figures.  The bold numbers (arrows)  indicate how many cells 
were required to reduce the eytotoxicity of the anti-Gix serum sample to 50% lysis of 129 
thymocytes in the standard  cytotoxicity test. Note that these numbers signify ratios of ap- 
proximately 3:2:1  for quantitative  representation  of  Gix  on  the three  Gix  +  categories, 
Gix  ~: GIX  ~: Glxt. 
Figs. C and D  illustrate that on thymocytes of reciprocal hybrids from Gix  +  )<  Gix- 
matings there is 50% representation of Gix in comparison with the Gix  + parent. 1340  TtIE  Gix  SYSTEM 
life.  (c)  At least  one of the  GCSA- strains,  C3Hf/Bi  (Gix-),  can be called  a 
GCSA  conversion  strain  (10)  because  these  mice usually  become  GCSA  +  in 
later life, at which time they also show the other signs of overt MuLV infection, 
i.e.,  appearance  of virions and of MuLV-gs antigens.  The lymphoid tissues of 
such mice also become G~x  +. The complete change in phenotype can be written 
MuLV-: GCSA-: G~x- --~ MuLV+: GCSA+: Gix  +. 
TABLE III 
G  ix and GCSA Phenotypes of Malignant Cells of GCSA- Mouse Strains* 
GCSA- Gix  + strains 
GCSA-  Gix-  strains 
Pheno- 
types of 
malignant 
cells 
GCSA/GIx 
(+ 
+ 
-\_ 
f+ 
-/- 
Numbers observed 
Leukemias 
6 (incl. 1 Passage A 
Gross virus) 
5 (incl. 1 Passage A 
Gross virus) 
;8 (Moloney virus) 
\2 (Friend virus) 
8 (incl. 1 Rauscher 
virus) 
Mye- 
lomas 
(BALB/c) 
Other tumors 
3 (spont. mam- 
mary tumors) 
1 (sarcoma) 
$2 (sarcoma) 
\1 (melanoma) 
1 (sarcoma) 
* All spontaneous leukemias arising in GCSA  + strains  (prototype AKR) were GCSA+: 
Gix +. The purpose of this table is to illustrate that GCSA and Gix antigens can occur inde- 
pendently of one another on malignant ceils of both Gix  + and Gix- mouse strains. 
III.  G~x Phenotypes of Leukemias and Other Tumors (Table III): Appearance 
of G,x Antigen on Malignant Cells of Grx- Mice.--All spontaneous leukemias of 
the high-incidence AKR and C58 strains were G~x+: GCSA  +, as are the normal 
lymphoid tissues of these GCSA  + strains. 
Scoring for presence vs. absence of GCSA and  Gix antigens gives four pos- 
sible phenotypes: -4-+,  ~--,  ---}-, and  ----. All four were observed, both in 
G~x- strains and in G~x  + strains,  as Table III shows. 
Thus  G~x  is  often expressed  on the malignant  tissues  of G~x- mice,  as has 
already  been  shown  for  GCSA  in  GCSA-  mice  (1).  Leukemias  induced  by 
Friend,  Moloney,  and Rauscher,  variants  of MuLV,  were  G~x- showing that 
the  Gix-  ~  Glx  +  conversion  is  peculiar  to  infection  with  MuLV  (Gross), ELISABETH  STOCKER%  LLOYD  .1-  OLD,  EDWARD  A.  BOYSE  1341 
which is the common wild-type leukemia virus of the mouse. Of the four sar- 
comas  and  one  melanoma  tested,  all were  G~x- although  four  of them  were 
GCSA  +. This GCSA- --~ GCSA  + conversion in sarcomas is familiar from earlier 
studies showing the appearance of MuLV virions and MuLV  antigens in sar- 
comas of GCSA- mice (see 11 and 12). Three spontaneous mammary tumors, of 
C3H/An (2) and A(1), were GCSA+: Gix  +. 
IV.  Induction of Gzx Antigen in Rats Inoculated with MuLV  at Birth (Table 
IV).--Newborn  W/Fu  rats  are  exquisitely  sensitive  to  leukemogenesis  by 
MuLV  (Gross); inoculation of thymocytes from GCSA  +  mice induce leukemia 
TABLE IV 
Induction qf G  ix Antigen on Lymphoid Cells of Rats Inoculated at Birth with Passage A  Gross 
V#us or with Viable Thymocytes of GCSA  + Mice* 
Donor (mouse)~  Recipient  (rat) 
Strain  Phenotype  Phenotype 
C57BL/6, BALB/c  GCSA- Gix-  GCSA- Gix- 
129, A, I  GCSA- Gix  +  GCSA- GIX- 
C58, AKR  GCSA  + Gix  +  GCSA  + Gix  + 
Gross Passage A virus  --  GCSA  + Gix  + 
* Based on data from  70 recipient W/Fu rats tested  10-90 days after birth. In every 
instance thymocytes and spleen cells were tested separately and gave the same result. Re- 
cipient thymocytes were  tested with H-2  and TL antiserum and shown to be of recipient 
(rat) not donor  (mouse)  type. 
J; (8-15)  X  107 viable thymocytes injected i.p. into each newborn  (<24 hr old)  W/Fu rat 
recipient. In the case of AKR and BALB/c, both viable thymocytes and thymocyte filtrates 
were tested, and gave similar results.  Gix- --* Gix  + conversion  is seen to be produced by 
mouse thymocytes which produce MuLV, but not by mouse thymocytes that do not produce 
MuLV. 
in virtually 100 %  of recipients (5, 38). No trace of Gix antigen is demonstrable 
in any tissue of normal W/Fu  rats. 
Table IV summarizes numerous experiments in which thymocytes of W/Fu 
rats were tested for G~x antigen after neonatal injection of mouse thymocytes 
of various strains.  G~x- --* Gxx  +  conversion occurred in  the  thymocytes and 
spleen cells of all rats receiving thymocytes from the GCSA  + strains AKR and 
C58.  G~x- --* Gix  +  conversion of recipient rat  thymocytes was  also brought 
about by inoculation of filtrates of GCSA  ÷ thymocytes (Millipore No. 22), and 
of Passage A  Gross virus. Inoculation of thymocytes from GCSA- strains did 
not  produce  conversion,  regardless of whether  the  donor  of  the  thymocytes 
came from a  G~x  +  strain, like 129,  or from one of the G~x- strains. Thus  the 
G,x- --* G~x  + conversion is seen to be restricted to those preparations that con- 
tain infective MuLV (Gross) and induce leukemia in the rat. 1342  THE  GIx  SYSTEM 
V.  Genetics  of  G~x  Antigen  Expression  on  Thymocyles  (see  Appendix  for 
interpretation  of segregation ratios).-- 
(a)  Table  V: 747 mice of backcross matings of the type G~x3/Gix  -  )<  Gxx~/ 
G~x  3 have been scored for 100% vs. 50%  expression  of G~x  ~. The ratios  were 
370:377.  These  data indicate  segregation of a  single  gene.  This  gene is  semi- 
dominant,  i.e.,  +/+  is  distinguishable  from +/--.  Quantitative  absorption 
with thymocytes of selected individual mice showed no variation in the amount 
of G~x on thymocytes of different mice within each class, i.e., subclasses of the 
+/+  and +/-  categories were not distinguishable. 
TABLE V 
One-Gene Determination  of GTx Phenotype  in  Serial  Backcrosses of  C57BL/6  (Gzx-)  to 
Strain  129 (Grx 3) 
Glx phenotype 
++  (100% GIX  3) 
+  (50% GIX  3) 
Serial  backcross* generation number 
1  2  3  4  5  6  7  8  9  10 
20  4  5  4  19  21  20  18  13  33 
18  9  4  9  20:~  15  14  18  18  25:~ 
Genotype 
total  inferred 
157  Gzx3/G,x 3 
150  G  zx~/G zx- 
* The successive matings were set up from typed positive  (50% Gix 8) mice of the pre- 
ceding generations; use  of  9  vs.  o  z  backcross parents  had  no  effect on  the  segregation 
ratio. 
:~ Gix- mice, presumed genotype Gix-/Gzx- were selected from the progeny of matings 
among these groups and inbred to produce a 129/Gix- congenlc line (from the 5th and later 
from the 10th backcross generation). Further data are available from first generation back- 
crosses of CBA/J, C57BR/J, and BALB/c (all Gix-) to 129; these bring the total 129 strain 
backcross segregation data  (including the figures in this table)  to 370++  and 377+  (747 
mice in all). 
The serial backcross data shown in detail in Table V  confirm determination 
by a  single mendelian  gene, because the 1:1 ratio was maintained  through 10 
generations of backcrossing. Intercrossing of positive (50 %  GLx  3) segregants at 
the fifth backcross generation (=  NS),  and later at the 10th,  yielded a propor- 
tion of G~x- (--/-)  progeny as anticipated. Some of these negative segregants 
were inbred to provide the 129/Gix-  (N5)  congenic stock, which is now being 
replaced with  129/GIx-(N10). 
(b)  Table VI:  In mice of the reciprocal backcross, Gix~/Gix  -  X  Gix-/G~x-, 
the segregation data fit very closely to the expectation for two unlinked genes; 
40 positive: 116 negative (observed) vs. 39 positive: 117 negative (expected). 
(c)  Table VII:  To define the two-gene requirement further,  Gix  + segregants 
from the  fifth  serial  backcross  to  C57BL(GIx-)  identified  in  Table  VI  were 
intercrossed  and  typed for  G~x.  These  matings  yielded  the  anticipated  three 
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sion of G~x,  one gene semidominant and the other fully dominant. Segregants 
of  ++  (100%  Gix  3)  phenotype are being inbred to produce a  C57BL/GIx  3 
congenic stock. 
(d)  Table VIII:  Further confirmation of the two-gene requirement for G~x 
expression was obtained by typing 192  F2 mice from Gix3/G~x  -  X  GIxa/Gix  - 
TABLE VI 
Two-Gene Determination of GIX Phenotype in Serial Bavkcrosses of  Strain  129  (Gxx  3)  to 
C57BL/6  (Gzx-) 
Serial backcross* generation number  Total 
GIX phenotype  Genotype inferred 
S  6  7  Observed  Expected:~ 
"-[- (50% GIX  3)  25§  7  8  40  39  GIx3/GIx - 
-- (GIx-)  71  23  22  116  117  G[x-/Grx- 
* The matings were set up from either  9  or o  ~ heterozygotes; this had no effect on the 
segregation ratio. 
:~ On the  assumption  that two dominant unlinked genes are required for expression of 
G Ix; the result implies that one of them is semidominant and the second fully dominant, for 
in the backcross to strain 129 there were only two phenotypes and they occurred in a 1  : 1 
ratio (see Table V and Appendix). 
§ Mice of this group were crossed inter se, and the segregation data are given in Table VII. 
TABLE VII 
Two-Gene Determination of Gxx Phenotype in Progeny of Intervrosses of Gzx + Segregants of 
Fifth Backcross of Strain 129 (Glx 3) to C57BL/6  (G1x-)* 
GIX phenotype  Observed  Expected:t  Genotype inferred 
--]---~ (100% GIX  3)  19§  19  Glx3/Gix  3 
--]-  (50%  GIX  3)  35  39  GIxg/GIx - 
--  (Gix-)  49  45  Gxx-/Gxx- 
Total  103  103 
* The parent mice are identified in Table VI. 
1~ On the assumption that two unlinked genes, one fully dominant and the other  semi- 
dominant, are required for expression of Gix (see Appendix). 
§ These mice are being inbred to produce the C57BL/GIx  3 congenic stock. 
matings. Again the ratios of the three classes conform to control of Gix expres- 
sion by one fully dominant gene and one semidominant  gene. 
(e)  Table IX:  Linkage tests have located the semidominant gene in group 
IX,  suggesting the  symbol Gix  (Gross,x).  The distance of  Gxx  from  H-2 is 
36.4  =t=  2.7  units.  (Linkage tests  with  the following markers were  negative: 
Ly-A, Ly-B, Gpd-1, Id-1, Lv, and Mdh-1. Typing for biochemical markers was 1344  THE  Gix  SYSTEM 
performed by Dr. J. J. Hutton,  Roche Institute of Molecular Biology, Nutley, 
N.J.)  The  results  of  three-point  tests  to  determine  whether  Gix  is  distal  or 
proximal to H-2 are not yet available. 
Note Added in Proof.--A three-point cross involving T  (brachyury), H-2, and 
Gix gives the order T:H-2:GIx. 
TABLE VIII 
Two-Gene Determination  of  Gxx  Phenotype  in  F~  Generation* of  Crosses between  Strain 
129  (Gzx 3)  and  C57BL/6  (Grx-) 
GIX phenotype  Observed  Expected:~  Genotype  inferred 
++  (100% Gix 3)  37  36  Gzx3/Gzx  ~ 
+  (50% Gix ~)  70  72  Gzx3/Gzx  - 
--  (Glx-)  85  84  Glx-/Gxx- 
Total  192  192 
* From matings of (129 X  C57BL/6) or reciprocal F1 mice; separate calculations for the 
reciprocal matings showed no significant difference in segregation ratios. 
:~ On the assumption  that  expression of GIX depends  on two unlinked  genes,  the first 
semidominant  (+/+  distinguished from +/--)  and  the second fully dominant  (+/+  in- 
distinguishable from +/--), as the data in Tables V, VI, and VII require (see Appendix). 
TABLE  IX 
Linkage of Gzx with H-2 
Parental  Recombinant 
(a)  Combined data for the crosses  (CBA/J X  129) 9 9  X  129 and (C57BR/J  X  129) 99 
X  129" 
H-2 k+: Gix  +  64  H-2 k+: GIX++  41 
H-2 k--:Gix  ++  78  H-2 k--: GIX  +  50 
Total  142  91 
(b)  Combined  data  for  the  crosses  129  ~9  )<  (CBA/J  X  129) and  129  ~9  X 
(C57BR/J X  129)* 
H-2 k+ : Gix  +  37  H-2 k+: GIx++  12 
H-2 k--: Gix++  29  H-2 k--: GIX  +  16 
Total  66  28 
Mice typed for H-2 k by the cytotoxicity test on lymph node lymphocytes. Estimated map 
distance 36.4 4- 2.7 units, chi  2 =  25.4, P  <  0.001  (combined data, 208 parental: 119 recom- 
binant). 
* Phenotypes, CB  A/J and C 57B R/J are H-2 k+: Gix-. 129 is H-2 k--: G ix  ++. 
Gix  ++ =  100%  GIX  3 phenotype 
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DISCUSSION 
G,x as an Allo-A ntigen.--Gix meets the criteria of an allo-antigen; it is present 
in some strains and absent in others, it is expressed in half-quantity in hetero- 
zygotes, and the segregation data are mendelian. 
A two-gene requirement for expression of a cell surface antigen is a new find- 
ing in the mouse, but has precedents elsewhere; e.g. expression of the A and B 
blood  group phenotypes in  man requires  that  the  allele H  is  present  at  the 
unlinked Hh locus (39).  Restriction of G~x antigen  to lymphoid  tissue  is  not 
unusual, in fact the majority of serologically demonstrable lymphoid cell surface 
antigens  of the  mouse  are not  represented  on  other  tissues  (40).  These  two 
properties therefore are not exceptional. 
But  Gix  has  other  properties  which  are  not  those  of  conventional  allo- 
antigens, and these should be noted particularly for their possible relevance to 
the question whether Gix is coded by a  viral or a  cellular gene.  (a)  Foremost 
among these is the induction of G~x antigen in the lymphoid cells of newborn 
rats inoculated with MuLV. (b) Although the amount of Gix antigen on thymo- 
cytes  of normal mice is  a  constant  property characteristic  of each  strain  of 
mouse, mouse strains differ in the amount of  Gix  antigen  which they express. 
Most  Gix  +  mouse strains fall into one of three categories,  possessing a  high, 
intermediate,  or low amount of Gix,  approximately in the ratios 3:2:1.  This 
may be compared with the reduced amount of H-2 (D) antigen on thymocytes 
of TL  + strain mice as compared with TL- strain mice (41). But with this excep- 
tion there is no parallel with these fixed quantitative differences in representa- 
tion  of an antigen from strain  to strain.  Possibly the ratios 3:2:1  reflect the 
number  of MuLV  gene  copies present  in  the  respective strains.  (c)  A  third 
exceptional property is the appearance of Gix on leukemias and other malignant 
cells of Gix- strains.  Similarly, in mice of certain  strains  that show signs  of 
overt MuLV infection in  later life (conversion strains, see footnote to Table I) 
this event is accompanied by phenotypic conversion of their lymphoid cells from 
G~x- -+ Gix  +.  A  comparable conversion from negative to positive is seen in 
the TL system of allo-antigens, where TL  + leukemias occur in strains of mice 
that are TL-, i.e.,  in mouse strains that normally express no TL antigens (40). 
The same explanation is offered in both cases, namely that the relevant struc- 
tural genes are present throughout the species and are normally controlled by 
other genes with alleles that govern expression vs. nonexpression of the  struc- 
tural genes coding for the G~x and TL antigens.  (d)  In conventional systems 
of allo-antigens it is usual to find that every member of a species expresses one 
or  another  of  the  number  of  alternative  specificities  coded  by  alternative 
alleles. In the Gix and TL systems however, alternative antigens representing 
alleles of the structural genes have not been observed, and indeed their occur- 
rence would  be incompatible with  the ubiquity  of the  same structural  genes 
throughout the species, as discussed above (and 40). Strains therefore differ in 1346  THE  GIX  SYSTEM 
respect of expression vs. nonexpression of GIx and TL antigens, rather than in 
expressing alternative specificities. This does not itself signify that the struc- 
tural genes are likely to be viral rather than cellular,  because for example an 
amorph of a  cellular structural  gene (defined as an allele producing no recog- 
nizable product) gives the same negative phenotype as that produced when the 
pertinent structural gene is present but not expressed because there is a  non- 
expression allele at a  controlling locus.  The Bombay blood type in  man  is  a 
case in point,  genes for A  and B  antigens being present but not expressed be- 
cause of the absence of the allele H  at the distant 11h locus (39).  And further- 
more there is a priori no reason why a viral gene coding for a cell surface anti- 
gen should not exhibit variation and so specify alternative antigens. 
The G~x and Tla Loci Compared.--Ever  since the TL antigens were first de- 
scribed,  suggestions have been made about their possible origin from a  viral 
genome integrated in chromosome IX (42, 43). The fact that all known leukemia 
viruses are of RNA type seemed to tell against this at the time, for no mecha- 
nism of making DNA copies seemed to be available. Not only has such a mecha- 
nism since been recognized,  but we can now point to an important similarity 
to the Gix system which we know is intimately associated with a leukemia virus. 
The resemblance is that both G~x and TL antigens appear anomalously in the 
leukemias of mouse strains that  normally do not express them. Thus there is 
now a  somewhat better case for regarding  Tla as an integrated viral genome. 
(Note that G~x- --~ G~x  + conversion implies productive MuLV infection which 
may or may not  be immediately  associated with  malignant  transformation, 
whereas TL- --~ TL  + conversion is absolutely diagnostic of malignancy.) 
The Gxz and  Tla loci,  both of which specify antigens confined to lymphoid 
cells and both of which are intimately connected with  leukemogenesis, are also 
both situated in group IX [as is also a  third locus,  Rgv  (44),  a  strong deter- 
minant of susceptibility to leukemia induction by Gross virus (45)  situated at 
the K  end of tt-2 (46)]. But no obviously useful conclusion seems to follow from 
this  linkage  at  the moment.  The  Gxx and  Tla loci  are in  any event  widely 
separated,  and  anomalous  expression of genes  at  these loci  occurs independ- 
ently  during  leukemogenesis  i.e.,  leukemias  of  G~x-:TL-  strains  may  be 
G~x-: TL-, G~x  +: TL-, G,x-: TL  +, or GLx  +: TL  +. 
With  regard  to  oncornaviruses  as  a  group  (47),  (oncogenic  RNA  viruses 
including  the  leukemia-sarcoma  viruses  of  chicken,  the  mouse  mammary 
tumor virus, and leukemia and sarcoma viruses of several mammalian species 
including  the  mouse),  it  is  known  that  sometimes  only  a  part  of  the  viral 
genome is expressed in infected  cells.  Hamster tumors induced  by Rous  sar- 
coma virus, for example, have gs viral antigen but produce no virions or en- 
velope antigens (48). Thus the occurrence of G~x antigen in the absence of other 
MuLV  antigens,  as  in  the  thymocytes of  129  mice  or  in  myeloma cells  of 
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system, no connection between virions and the presence or induction of antigen 
has ever been established.) Thus there is a tantalizing correspondence between 
the two systems that awaits further elucidation. 
The Nature  of the  Two Chromosomal  Genes.--To  recapitulate,  the segrega- 
tion  data,  gathered  from  reciprocal backcrosses,  F2  populations,  and  inter- 
crosses of serially backcrossed heterozygotes, indicate unmistakably  (a)  that 
two unlinked dominant genes are required for the expression of Gix antigen, 
(b)  that one gene is fully dominant (+/--  indistinguishable from +/+)  and 
the other semidominant (+/--  quantitatively distinguishable from +/+,  and 
(c) that the latter is loosely linked with H-2 in strain 129 mice. 
But the G~x  + phenotype may also be acquired by the cells of G~x- mice, 
i.e. mice that do not normally express this antigen; this we refer to as pheno- 
typic conversion, GL<- --~ G~x  +. With the exceptions indicated by Table III 
this happens only when productive MuLV infection occurs in the cell popula- 
tion concerned (which in turn is believed to represent release of MuLV from a 
previous latent state rather than primary exogenous infection, (see refs. 2,  10, 
49). This event, MuLV- --* MuLV  + conversion, occurs (a) in the lymphoid tis- 
sues of older mice belonging to certain GLX- strains (10, 13), and (b) frequently 
in leukemias and other tumors of G~x- mouse strains (11,  13). 
In summary, the Gix  + phenotype is either inherited as a mendelian trait with 
full penetrance, like any other allo-antigen, or it is acquired as a consequence of 
productive MuLV infection. [Because it is not immediately germane to the Gix 
system, we shall not discuss why MuLV- --~ MuLV  + conversion so commonly 
accompanies malignancy (2, 11, 13). Nor shall we discuss why some malignant 
cells have the unusual phenotype G~x+:GCSA  -  or GIx-:GCSA  +  (Table III) 
for the significance of this is far from clear.] 
These findings invite the following interrelated questions:  (a)  Is  the gene 
coding for Gix antigen viral or cellular? (b) Can it be identified with either of 
the two chromosomal genes which are necessary for its expression in 129 mice? 
(c) Do the data indicate that MuLV is integrated at either of the chromosomal 
sites identified in the 129 genome? 
There are  two  reasons for not  undertaking  a  lengthy discussion  of  these 
questions now.  First,  no highly probable answer  to any one of them can be 
given at the moment. Secondly, continued study along the lines discussed in this 
report may provide the data necessary for reaching these important decisions 
relatively soon,  and  so  obviate  a  necessarily inconclusive discussion.  A  few 
comments will suffice to indicate the outstanding problems to be solved. 
If G~x antigen were a component of the virion, many of the following con- 
siderations would be redundant. But this is unlikely, although it is not yet quite 
excluded. The evidence against it so far is: (a)  Monospecific rat antisera pre- 
pared against five structural proteins of MuLV (Gross) by  R.  Nowinski were 
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sera  are cytotoxic for cells productively infected with  MuLV.  (b)  Myelomas 
producing MuLV  (Gross) may be GCSA+: Gix-; [but it could well be argued 
that  G~x happens to be lacking from a  so-far-unclassified subtype of  MuLV 
(Gross) responsible for this exceptional phenotype]. (c) Thymocytes of 129 mice 
(Gix  3)  do not produce virions (Aoki, T., unpublished work) and lack all MuLV 
antigens  other  than  G~x3; [but  this  could  be  attributed  to  differential  ex- 
pression  of MuLV  genes].  More critical tests are now in hand to confirm that 
Gix is not a component of the virion. The likelihood  that  Gix antigen is not a 
component of the virion leaves us with no hint as to whether the gene that spec- 
ifies it belongs to the cell or to MuLV. 
According to one hypothesis, Gix antigen may be specified by a cellular gene 
which is normally expressed in some (Gix  +)  strains of mice and not in others 
(nor in the rat),  this gene being activated or derepressed in the cells of G~x- 
mouse strains (and of the rat) as a result of productive MuLV infection. It is 
particularly necessary to entertain  this possibility in view of precedents  else- 
where, notably: (a) The TL- --* TL  + conversion accompanying leukemogenesis 
(40)  which signifies aberrant expression of chromosomal genes at the Tla locus 
and  (b)  the  appearance on malignant cells of antigens  that are normally ap- 
parent only on cells that have been trypsinized (50)  or on embryo cells  (51). 
There  is in  fact no cogent  evidence against  the hypothesis  that  G~x  antigen 
may be coded by a cellular gene that can be switched on by MuLV,  although 
this entails some complexities of specification, as we shall see. 
But  before  going  further,  let's  consider  whether  either  of  the  two 
identified chromosomal genes can be recognized as the gene coding directly for 
Gix antigen,  lit will be convenient from now on to refer to this gene, i.e.,  the 
gene directly specifying  G~x antigen, as str,  in contrast to epistatic genes gov- 
erning its expression. In the case of carbohydrate antigens such as the AB blood 
group  substances  there  can be no  structural  gene  coding  for  the  antigen  di- 
rectly, but it is implicit in this discussion that  if G~x antigen were a  carbohy- 
drate  rather  than  a  protein,  then the gene referred to as structural  would  in 
fact code for the enzyme responsible for imparting Gix specificity to the back- 
bone molecule.] This question is complicated by uncertainty  as to whether str 
belongs to the genome of the mouse or to the genome of MuLV. In either event 
it must be present in all mouse strains because all strains of mice may express 
it,  either congenitally as a  mendelian  trait or sporadically in  MuLV-infected 
normal or malignant cells,  as outlined above. 
Accordingly suppose (a)  that str is a  cellular gene.  Since it is present in all 
mice and so cannot segregate in crosses, it automatically is distinguished from 
both of the chromosomal genes, for the latter were identified by the fact of their 
segregation. This would mean that the two chromosomal genes control the G~x  + 
phenotype indirectly  and  that str  is a  third  gene  (which may or may not be 
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Alternatively, suppose (b)  that str is an MuLV gene. The interpretation in 
this case is less obvious, for the reason that it is not safe to assume (as one can 
in the case of a cellular gene) that the only possible location for str is the place 
where it resides in 129 mice. In other words there is no certainty that str,  if it 
belongs to MuLV, must necessarily be integrated at the same place in all strains 
of mice or even that it must always be integrated at all. This being so, it follows 
that expression vs.  nonexpression of str might be bound up with the state or 
site of the MuLV genome to which it belongs; in this case its expression in 
G~x  + mice might be conditional on integration  at  a  particular  chromosomal 
site, as in 129 mice. So str, although common to all mice, could in this way yield 
conventional segregatin ratios for the phenotypes Grx  + versus Gix-. 
This argument is entirely speculative, but it serves the purpose of showing 
that the genetic data involving expression of G~x antigen in 129 mice can be 
accommodated within a  framework of two rather than three genes,  one con- 
trolling expression and the other str, if the latter is assumed to constitute part 
of the MuLV genome. 
As to how the expression of a cell surface antigen may be controlled by a gene 
epistatic  to its structural  gene,  the first choice lies between  (a)  mechanisms 
typified by the regulation of protein synthesis in bacteria and (b)  those that 
involve sequential steps in biosynthesis. The latter are illustrated by the human 
AB blood group specificities, which can be produced only after H  specificity 
has been conferred on the backbone molecule by the action of the unlinked 
//h locus (39). In the case of Gix, either of these mechanisms is possible and 
neither is specially favored by the data available. 
In studying the nature of the two chromosomal loci further, given our now 
extensive knowledge of the ecology and immunology of MuLV, we may hope 
to  obtain further insight  into  the intimate  relations  of indigenous  leukemia 
viruses with the cells of the host species. 
SUMMARY 
This report concerns a cell surface antigen (Gix; G  =  Gross) which exhibits 
mendelian inheritance but which also appears de now  in cells that become pro- 
ductively infected with  MuLV  (Gross),  the wild-type leukemia virus  of the 
mouse. 
In normal mice, Gix is a cell surface allo-antigen confined to lymphoid cells 
and found in highest amount on thymocytes. Four categories of inbred mouse 
strains can be distinguished according to how much Gix antigen is expressed on 
their thymocytes. Gix- strains have none; in the three G~x  + categories, G~x  3, 
Gix  2, and G~x  I,  the amounts of Gix antigen present (per thymocyte) are ap- 
proximately in the ratios 3: 2 : 1. 
A  study  of  segregating  populations  derived mainly from strain  129  (the 
prototype Gix  3 strain) and C57BL/6 (the prototype G~x- strain) revealed that 1350  THE Oix  SYSTEM 
two unlinked chromosomal genes are required for expression of Gix on normal 
lymphoid  cells.  The phenotype  Gix  +  is  expressed only when both genes  are 
present, as in 129 mice. C57BL/6 carries neither of them. 
At one locus,  expression of GIx is fully dominant  over nonexpression (Gix 
fully expressed in heterozygotes). At the second locus, which is linked with H-2 
(at a distance of 36.4 -4- 2.7  units) in group IX (locus symbol Gzx), expression 
is semidominant (50% expression of Gix in heterozygotes); gene order T:H-2: 
Tla: Gzx. 
As a rule, when cells of GIx- mice or rats become overtly infected with MuLV 
(Gross),  an event which occurs spontaneously in older mice of certain strains 
and which also commonly accompanies malignant transformation, their pheno- 
type  is  converted  to  Gix  +.  This  invites  comparison  with  the  emergence  of 
TL  + leukemia cells in TL- mouse strains which has been observed in previous 
studies and which implies that TL- --~ TL  + conversion has accompanied leu- 
kemic transformation of such cells.  So far the only example of Gix- --~ Gix  + 
conversion taking place without  overt MuLV infection is represented by  the 
occurrence of GCSA-:GIx  + myelomas in BALB/c (GCSA-: Gix-) mice. 
Unlike the other Gross cell surface antigen described earlier, GCSA, which is 
invariably associated with MuLV (Gross) infection and never occurs in its ab- 
sence,  Gix  antigen  sometimes  occurs  independently  of  productive  MuLV 
infection; for example, thymocytes and some leukemias of 129 mice are GCSA-: 
G,x  +,  and MuLV-producing sarcomas may be GCSA+:GIx  -. 
The frequent emergence of cells of Gix  + phenotype in all mouse strains im- 
plies that  the structural  gene coding for G~x antigen  is common to all mice. 
There is precedent for this in the TL system, in which two of the Tla genes in 
linkage group IX appear to be ubiquitous  among mice, but are normally ex- 
pressed only in strains of mice carrying a second (expression) gene. 
It is not yet certain whether either of the two segregating genes belongs to the 
MuLV genome rather than  to the cellular genome.  This leaves the question 
whether MuLV may have a  chromosomal integration site still debatable. But 
there is a  good prospect that further genetic analysis will provide the answer 
and so elucidate the special relationship of leukemia viruses to the cells of their 
natural hosts. 
Discussions with Drs. K. Itakura and R. C. Nowinski have been most helpful. The assist- 
ance of Miss C. A. Iritani, Miss L. Hubbard, and Miss G. Sarner in the conduct of this work 
Was indispensible. 
APPENDIX 
These notes on determination of expected segregation  ratios are appended at the 
suggestion of readers who offered comments on the manuscript. ELISABETH  STOCKERT, LLOYD J,  OLD, EDWARD A.  BOYSE  1351 
The observed segregation ratios signify that expression of Gix antigen in 129 mice 
requires one fully dominant gene and one unlinked semidominant gene. The segrega- 
tion ratios expected from this mode of determination are illustrated in these notes. 
Let the two genes be D  (dominant) and S  (semidominant), their recessive  (non- 
expression) alleles being indicated (-).  Then the genotypes are: 
129:DDSS, 
C57BL/6 : ....  , 
(129  X  C57BL/6)Fl:D-S-. 
(a)  For the backcross to 129 (D-S-  X  DDSS): 
Expected proportion  of 
Genotype  Phenotype  backcross mice of each 
phenotype 
SS~  GIx  ++ (100% expression)  !  DD 
D--SSJ 
DDS--~  ! 
D-S-J  2  Gix  %  (50% expression) 
Only the segregation of S is evident in this cross, because DD gives the same pheno- 
type as D -  (100% Gix expression in both DD  and D -mice) ; hence the  single-gene 
segregation ratio 1 : 1. 
(b)  For the backcross to C57BL/6  (D-S-  X  ....  ): 
Expected proportion of 
Genotype  Phenotype  backcross mice of each 
phenotype 
D -- S-  GIx  +  (50% expression)  1 
GIx- (no expression) 
In this cross the segregation of both genes is evident, hence the two-gene ratio 1 : 3. 
(c)  For the F2 generation  (D-S-  X  D-S-): 
F1 gametes 
Fx gametes 
DS  D--  --S 
i  DS  DDSS DDS-- D--SS D--S-- 
D--  DDS-- DD----  D--S--  D------ 
--S  D--SS  D--S--  ----SS  ----S-- 
----  D--S--  D  S 
Genotypes of F2 
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Expected proportion of F2 
Genotype  Phenotype  mice of each phenotype 
DD  SS  (1)\ 
D--  S S  (2) f 
D D  S --  (2)~ 
D-  S-  (4)  3 
DD----  (1)1 
D  --  --  (2) i 
----  S  S  (1)  I 
s  -  (2) [ 
(1)) 
Total  16 
GIX  ++ (100% expression)  16 
GIx  + (50% expression)  i~ 
Gix- (no expression)  ~16 
The expected ratios of the three phenotypes are therefore 3 : 6: 7. 
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